16 results on '"Tunn, U.W."'
Search Results
2. P110 Efficacy and tolerability of 3- and 6-month depot formulations of leuprorelin acetate for advanced prostate cancer in daily clinical practice: Pooled data from 2 non-interventional studies
3. PO-233 INTENSITY MODULATED HIGH-DOSE-RATE BRACHYTHERAPY AS MONOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER
4. Advanced prostate cancer treatment guidelines: European perspective
5. Assessment and management of high‐risk patients
6. Management of prostate-specific antigen relapse in prostate cancer: A European consensus
7. 181 New 3D interstitial HDR brachytherapy technique combined with 3D external beam radiotherapy and androgen deprivation for localized prostate cancer: Preliminary results
8. 146 Dose-volume histograms (DVH) and a conformal index (COIN) to evaluate implant quality of a new hdr brachytherapy technique for prostate cancer: Results in 616 implants
9. Intermittent Androgen Blockade in Prostate Cancer: Rationale and Clinical Experience
10. The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer
11. Comparison of LH-RH Analogue 1-Month Depot and 3-Month Depot by Their Hormone Levels and Pharmacokinetic Profile in Patients with Advanced Prostate Cancer
12. Intermittent Endocrine Therapy of Prostate Cancer
13. Placebo Controlled Double-blind Study to Test the Efficacy of the Aromatase Inhibitor Atamestane in Patients with Benign Prostatic Hyperplasia not Requiring Operation
14. Mitomycin C Versus Estramustine in the Treatment of Hormone Resistant Metastatic Prostate Cancer: Thefinal Analysis of the European Organization Forresearch and Treatment of Cancer, Genitourinarygroup Prospective Randomized Phase III Study (30865)
15. Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors
16. Effects of estrogen deprivation on human benign prostatic hyperplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.